Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 August 2021 | Story Leonie Bolleurs | Photo Supplied
Tinus Viljoen (second from the left) is responsible for waste management at the university. Here he is pictured at the new chemical waste facility on the western side of the Bloemfontein Campus. With him, on his left, is Nico Janse van Rensburg, Senior Director, University Estates; Prof Danie Vermeulen, Dean of the Faculty of Natural and Agricultural Sciences; and on the far right is Benedict Mochesela, officer at University Estates.

A new chemical waste facility on the western side of the Bloemfontein Campus started functioning in July 2021 and will enhance the safe storage of hazardous materials on campus.

Since the safety of its staff and students are a key priority for the university, as stipulated in its strategic plan, a facility such as this plays an essential role in reducing any health risks and even the possibility of an explosion.

Tinus Viljoen, a Lecturer in the Department of Genetics, concurs that this facility makes the university a safer place because there are less toxic and flammable waste lying around in the labs. 

Besides his role as lecturer, he is responsible for waste management, including the collection of hazardous waste internally, classifying it, and arranging for it to be collected by accredited waste companies. 

A safer space

Waste previously stored in the Genetics Building is now kept at the new facility. Viljoen is of the opinion that this new space is safer because fewer students and staff have access to the western campus. “The chemical waste tends to smell, and on this part of the campus it is out of the way,” he says.

He also says that it helps to have a central place to store the waste, because of logistical reasons. “It makes the overall waste management easier.”

It is mainly inorganic and organic liquid/solid waste, contaminated glass, contaminated solids (e.g., filter paper and gloves), acid waste, and expired chemicals that are stored at the facility. 

This facility makes the university a safer place because there are less toxic and flammable waste lying around in the labs. – Tinus Viljoen

Adhering to legislation

He explains that he is notified by departments in the Faculty of Natural and Agricultural Sciences when they have waste to collect and that he then collects it on Fridays.

Viljoen continues: “The chemical waste is then classified according to the various waste streams and stored in large 210 l drums. When the drums are full, I contact an accredited hazardous waste company to remove, transport, and dispose of the various waste according to strict legislation, constituting the National Environmental Management Act (Act 107 of 1998), the National Environmental Management: Waste Act, 2008 (Act 59 of 2008), the Hazardous Substances Act (Act 5 of 1973), and the National Road Traffic Act, 93 of 1996 (NRTA).”

“The majority of the waste is transported to a hazardous landfill in Gauteng and the rest are incinerated,” he concludes. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept